MetLife shares show resilience as analysts upgrade outlook following strong Q1 earnings
New York-based insurer reports adjusted earnings per share of $2.42, beating expectations and prompting positive sentiment from Mizuho Financial Group and others.
MetLife Inc. has emerged as a focal point for Wall Street strategists, with a distinct shift in sentiment following its first-quarter 2026 financial results. Despite the stock underperforming the broader market over the last twelve months, analysts have upgraded their collective outlook, now favouring a 'Moderate Buy' rating based on robust underlying performance.
The divergence between the insurer's trajectory and the wider market remains stark. While the S&P 500 Index rallied nearly 30.6% over the past year, MetLife shares have gained only marginally. This trend continues into the current year, with the stock down 1.1% year-to-date compared to the S&P 500's 8.1% rise, and trailing the iShares U.S. Insurance ETF, which has also seen declines over the same period.
However, the recent quarterly report has altered this narrative. MetLife reported adjusted earnings per share of $2.42, a significant 23.5% increase from the previous year. Revenue for the quarter reached $19.1 billion, reflecting a solid 2.7% growth. These figures have provided the foundation for the renewed optimism among the nineteen analysts currently covering the New York-based global provider of insurance, annuities, and employee benefits.
The consensus rating among these analysts has moved to 'Moderate Buy', a configuration driven by eleven 'Strong Buy' ratings, one 'Moderate Buy', and seven 'Holds'. This represents a more bullish stance than two months ago, with no analyst currently suggesting a neutral 'Moderate Buy' rating. Looking ahead, the group projects full-year diluted earnings per share growth of 11.3%, with estimates pointing to $9.89 for the fiscal year ending in December.
Specific recommendations from major institutions highlight the potential upside. Mizuho Financial Group analyst Yaron Kinar maintains an 'Outperform' rating on the stock, having raised his price target to $95. This implies a potential gain of 21.7% from current levels. Across the board, the mean price target sits at $91.19, representing a 16.8% premium to current trading levels, while the Street-high target reaches $106.
While the company's earnings surprise history has been mixed, having beaten consensus in three of the last four quarters, the current data suggests a stabilising trend. The market capitalisation of approximately $50.9 billion now reflects a recalibration of investor sentiment, balancing recent underperformance against the demonstrated strength in its core financial services operations.
